Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing-remitting multiple sclerosis.

Gao, Jiali; Jones, Joanne; Damato, Erika M; Coles, Alasdair

Acute posterior multifocal placoid pigment epitheliopathy after alemtuzumab treatment for relapsing-remitting multiple sclerosis.

Accepted version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/291229

Repository DOI

https://doi.org/10.17863/CAM.38408

Files

Accepted version (26.39 KB)

Type

Article

Authors

Gao, Jiali

https://orcid.org/0000-0002-5461-1742

Jones, Joanne

Damato, Erika M

Coles, Alasdair

Keywords

APMPPE—acute posterior multifocal placoid pigment epitheliopathy, Alemtuzumab, Autoimmunity, Multiple sclerosis, Adult, Alemtuzumab, Antineoplastic Agents, Immunological, Eye, Female, Humans, Multiple Sclerosis, Relapsing-Remitting, Treatment Outcome, White Dot Syndromes

Journal Title

J Neurol

Journal ISSN

0340-5354
1432-1459

Volume Title

266

Publisher

Springer Science and Business Media LLC

Publisher DOI

https://doi.org/10.1007/s00415-019-09288-y

Rights

Sponsorship

Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
MULTIPLE SCLEROSIS SOCIETY (39)
Medical Research Council (G1100114)

Collections

Cambridge University Research Outputs